CCEL Q2 2019 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q2 2019 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+24.6% YoY

Gross Profit

$5M67.7% margin

Operating Income

$496,5646.1% margin

Net Income

$53,6730.7% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$558,979

Free Cash Flow

$199,194

Stock-Based Comp.

$86,827

Balance Sheet

Total Assets

$41M

Total Liabilities

$49M

Stockholders' Equity

-$8M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+24.6%
Gross Profit	$5M	$5M	+15.8%
Operating Income	$496,564	$1M	-56.8%
Net Income	$53,673	$539,506	-90.1%

Revenue Segments

Processing and Storage Fees

$8M92%

Public Banking

$234,1153%

Public Banking Revenue

$234,1153%

Licensee And Royalty Income Recognition

$201,8282%

Product

$12,0400%

Product Revenue

$12,0400%

Geographic Segments

INDIA

$201,828100%